1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsVision Research (various grant mechanisms under PA-00-009) is sponsored by National Eye Institute (NEI). The NEI supports research investigating the causes, mechanisms, and treatments for retinal diseases, with the goal of preserving and restoring sight through retinal repair.
Get alerted about grants like this
Save a search for “National Eye Institute (NEI)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Vision Research Grants and Funding – How to Apply NEI funds research supporting our mission to eliminate vision loss and improve quality of life across the country. See our research priorities and learn how to apply for a grant or funding for your project.
Understanding our Priorities Explore some of our research program areas below: We support research investigating the causes, mechanisms and treatments for retinal diseases, with the goal of preserving and restoring sight through retinal repair.
Get more details on retinal research Glaucoma and Optic Neuropathies We advance research on molecular genetics, physiologic mechanisms, diagnostic methods, and treatments for glaucoma and other optic neuropathies.
Get more details on glaucoma and optic neuropathies research Low Vision and Blindness Rehabilitation NEI-funded research aims to increase understanding of vision loss, to unlock treatments to restore sight, and to develop technologies and training to improve quality of life for people with visual impairments. Get more details on low vision and blindness rehabilitation See more research priorities Your path to NEI funding starts here.
See our list of opportunities, learn how to apply, and read about our important policies and compliance standards. Explore NIH’s Grants & Funding search page (from the Office of Extramural Research) to find up-to-date information about NIH funding, including all NEI-related programs and opportunities.
Learn how to fund your research Read the policies and procedures related to NEI-funded research, including guidance on rigor and reproducibility, data integrity, and participant safety. Learn about our policies and compliance Our investment in vision research goes beyond funding. NEI’s expertise and a library of research resources are available to help grantees advance their work.
Resources for Researchers Explore our resources for vision researchers, including essential information for current grantees. Contact Our Grants and Funding Staff Have a question about NEI funding? We can help.
NEI supports the next generation of scientists and innovators in vision research. Get an inside look at how NEI-funded scientists find their footing, and change lives, in vision research. NEI’s mission is to eliminate vision loss and improve quality of life through vision research.
Learn how we’re bringing us closer to a world without vision loss by advancing the science that safeguards our sight. Every year, we lead or support dozens of clinical trials and studies focused on eye diseases. Participating in a clinical trial or study can help researchers provide new treatments, learn new information, and find new ways to help.
Learn about clinical studies, find opportunities to participate, and explore the impact of past studies. Learn about clinical trials Last updated: April 9, 2026
Based on current listing details, eligibility includes: Investigators with diverse scientific interests. Applications are accepted through various grant mechanisms including R01, STTR (R41, R42), SBIR (R43, R44), K08, K23, and K24, each with specific eligibility requirements. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Varies Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Past winners and funding trends for this program
Computational Approaches in Fundamental Neuroscience is sponsored by National Institute of Mental Health (NIMH), National Institute on Aging (NIA), National Center for Complementary and Integrative Health (NCCIH), National Eye Institute (NEI), National Institute on Drug Abuse (NIDA), Office of Research on Women's Health (ORWH) (National Institutes of Health). This program promotes the integration of computational approaches, including machine learning and AI algorithms, into fundamental neuroscience research. It encourages rigorous, hypothesis-driven multidisciplinary research to investigate molecular and cellular mechanisms underlying brain function in health and disease across the lifespan, relevant to cognitive, affective, and social domains.
Pigment Epithelium-Derived Factor Peptides and Their Use for Treating Retinal Degeneration is sponsored by National Eye Institute (NEI). NEI seeks partners to develop an AAV2-based delivery system or eyedrop formulation for PEDF peptides, aiming to treat inherited retinal diseases. This technology describes chemically synthesized peptide fragments derived from PEDF, a naturally occurring neurotrophic factor produced by retinal pigment epithelia, with the potential to treat multiple ophthalmological diseases.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.